n-(gamma-maleimidobutyryloxy)succinimide has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 1 studies
*Leukemia, Lymphocytic, Chronic, B-Cell: A chronic leukemia characterized by abnormal B-lymphocytes and often generalized lymphadenopathy. In patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (CLL); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. These terms represent spectrums of the same disease. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baloun, J; Doubek, M; Horák, D; Plichta, Z; Pospíšilová, Š; Proks, V; Studená, R; Svozilová, H | 1 |
1 other study(ies) available for n-(gamma-maleimidobutyryloxy)succinimide and Leukemia, Lymphocytic, Chronic, B-Cell
| Article | Year |
|---|---|
RGDS-Modified Superporous Poly(2-Hydroxyethyl Methacrylate)-Based Scaffolds as 3D In Vitro Leukemia Model.
Topics: Cell Culture Techniques; Cell Line, Tumor; Humans; Hydrogels; Leukemia, Lymphocytic, Chronic, B-Cell; Mesenchymal Stem Cells; Oligopeptides; Porosity; Succinimides; Tissue Scaffolds | 2021 |